Gregory Dore

NSW_Premiers_Prize_winners.png

The pioneering researchers have been honoured for excellence in biological sciences, physical sciences and innovation. 

Destruction of hepatitis C virus, 3D illustration. Conceptual image for hepatitis C treatment

Hepatitis C testing and treatment in prisons is key to reducing infections, a new study by the Kirby Institute has shown.

Professor Gregory Dore

Professor Gregory Dore from The Kirby Institute at UNSW Sydney has won the prestigious 2020 Eureka Prize for infectious diseases research.

Surfer wearing a mask

A preliminary study published online this week estimates Australia had 60,000 undiagnosed COVID-19 infections by July. But there are a range of limitations to the study.

28_hepatitis_c.jpg

More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.

IStock 000026183969XSmall 1

The death of musician Lou Reed from liver cancer may raise awareness of the challenges of living with hepatitis C, but more work needs to be done to make sure treatments are widely available, writes Gregory Dore.